Nucleoside reverse transcriptase inhibitors appear to be neuroprotective, thus lowering the incidence of Alzheimer dementia.

The two active substances are antivirals that inhibit HIV reverse transcriptase through incorporation into the viral DNA, ...

Nucleoside reverse transcriptase inhibitors (NRTIs) are used to prevent HIV and hepatitis B from replicating and spreading ...

Doctor Jayakrishna Ambati and his research team have begun work on a new drug called K9 which could treat and prevent ...

The use of nucleoside reverse transcriptase inhibitors, but not other HIV medicines, is linked to a reduced risk for ...

Previously used to treat HIV and Hepatitis B, nucleoside reverse transcriptase inhibitors (NRTIs) reduced the risk of ...

A new UVA study finds that HIV drugs like NRTIs may reduce Alzheimer's risk by 10% annually, suggesting potential for ...

A new study has found that a common class of medications could dramatically decrease the risk of developing the neurodegenerative disorder.

Willie B. Thomas/Getty Images Researchers at UVA Health have found that a class of HIV drugs called nucleotide reverse transcriptase inhibitors (NRTIs) may significantly reduce the risk of ...

Scientists have identified a promising new class of treatments for Alzheimer's disease, and they're already widely used to ...

Researchers at UVA Health are urging for clinical trials to explore whether certain HIV medications, known as nucleoside reverse transcriptase inhibitors (NRTIs), can help prevent Alzheimer’s disease.

Scientists are calling for clinical trials to test the potential of HIV drugs called NRTIs to prevent Alzheimer’s disease ...